Exercise price of common units.

No definition available.

Name:	limn_CommonUnitExercisePricePerUnit
Namespace Prefix:	limn_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of common units exercised of limited liability company (LLC).

+ References

No definition available.

+ Details

Name:	limn_CommonUnitExercised
Namespace Prefix:	limn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of common units purchased of limited liability company (LLC).

+ References

No definition available.

+ Details

Name:	limn_CommonUnitPurchased
Namespace Prefix:	limn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Repurchase price per unit of common units.

+ References

No definition available.

+ Details

Name:	limn_CommonUnitRepurchasePricePerUnit
Namespace Prefix:	limn_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of common units repurchased of limited liability company (LLC).

+ References

No definition available.

+ Details

Name:	limn_CommonUnitRepurchased
Namespace Prefix:	limn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Value common units repurchased of limited liability company (LLC).

+ References

No definition available.

+ Details

Name:	limn_CommonUnitRepurchasedValue
Namespace Prefix:	limn_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	instant

- Definition

Number of member units terminated post the termination of license rights with Metavagen.

+ References

No definition available.

+ Details

Name:	limn_LicenseRightsNumberOfUnitsTerminated
Namespace Prefix:	limn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Number of member units exchanged as a consideration for license rights to develop, market and sell YN1203, InnoBation Bio CAR NK biomarkers, including devices, compounds and products used to detect analyte in body or tissue.

+ References

No definition available.

+ Details

Name:	limn_NumberOfUnitsExchangeForLicenseRights
Namespace Prefix:	limn_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Percentage of allocation of annual revenue and expenses to member units.

+ References

No definition available.

+ Details

Name:	limn_PercentageOfAllocationOfAnnualRevenueAndExpenses
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of allocation of liquidation value to member units.

+ References

No definition available.

+ Details

Name:	limn_PercentageOfAllocationOfLiquidationValue
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Percentage of allocation of voting rights to member units.

+ References

No definition available.

+ Details

Name:	limn_PercentageOfAllocationOfVotingInterest
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining percentage of allocation of annual revenue and expenses on a pro rata basis to remaining members.

+ References

No definition available.

+ Details

Name:	limn_RemainingPercentageOfAllocationOfAnnualRevenueAndExpensesOnProRataBasis
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining percentage of allocation of liquidation value on a pro rata basis to remaining members.

+ References

No definition available.

+ Details

Name:	limn_RemainingPercentageOfAllocationOfLiquidationValueOnProRataBasis
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Remaining percentage of allocation of voting interest on a pro rata basis to remaining members.

+ References

No definition available.

+ Details

Name:	limn_RemainingPercentageOfAllocationOfVotingInterestOnProRataBasis
Namespace Prefix:	limn_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	us-gaap_CapitalUnitLineItems
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

Stated value of common units of ownership issued by a limited liability company (LLC).

+ References

No definition available.

+ Details

Name:	us-gaap_CommonUnitIssuanceValue
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Number of common units issued of limited liability company (LLC).

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Topic 505
-SubTopic 10
-Name Accounting Standards Codification
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-Publisher FASB
-URI https://asc.fasb.org/1943274/2147480008/505-10-S99-1

+ Details

Name:	us-gaap_CommonUnitIssued
Namespace Prefix:	us-gaap_
Data Type:	xbrli:sharesItemType
Balance Type:	na
Period Type:	instant

- Definition

Per share or per unit amount of equity securities issued.

+ References

No definition available.

+ Details

Name:	us-gaap_SharesIssuedPricePerShare
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	instant

- Details

Name:	us-gaap_CapitalUnitsByClassAxis=us-gaap_CapitalUnitClassAMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	dei_LegalEntityAxis=limn_LiminatusPharmaLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_DebtInstrumentAxis=limn_ValetudoLoanMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=limn_MetavagenLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=limn_MetavagenLicenseAgreementsMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	srt_CounterpartyNameAxis=limn_CurisBiotechHoldingsLlcMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_TypeOfArrangementAxis=limn_Cd47LicenseAndDevelopmentAgreementWithInnobationMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	us-gaap_CapitalUnitsByClassAxis=us-gaap_CapitalUnitClassBMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

Members' Deficit (Details) - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Dec. 31, 2024	Mar. 31, 2023	Dec. 31, 2022	Oct. 31, 2022	May 31, 2022	Apr. 30, 2021	Jun. 11, 2018	May 20, 2018
Class A Member Units \| Liminatus Pharma, LLC
Members' Deficit
Units issued					8,400,000			10,000,000
Value of units issued					$ 4.2			$ 0.1
Units purchased							16,666,666
Exercise price							$ 0.01
Value of units exercised						$ 0.2
Price per unit					$ 0.5
Remaining percentage of allocation of annual revenue and expenses on a pro rata basis	49.00%
Remaining percentage of allocation of voting interest on pro rata basis	49.00%
Remaining percentage of allocation of liquidation value on pro rata basis	49.00%
Class A Member Units \| Valetudo Loan \| Liminatus Pharma, LLC
Members' Deficit
Units repurchased			1,400,000
Repurchase value			$ 0.7
Repurchase price per unit			$ 0.5
Class A Member Units \| Metavagen LLC ("Metavagen") \| Metavagen License Agreement \| Liminatus Pharma, LLC
Members' Deficit
Number of member units exchange for license rights to develop, market and sell YN1203, InnoBation Bio CAR NK biomarker			40,000,000
Number of member units terminated post termination of license rights		40,000,000
Class A Member Units \| Curis Biotech Holdings LLC \| CD47 License agreement with InnoBation
Members' Deficit
Number of member units exchange for license rights to develop, market and sell YN1203, InnoBation Bio CAR NK biomarker				78,555,554
Class A Member Units \| Curis Biotech Holdings LLC \| CD47 License agreement with InnoBation \| Liminatus Pharma, LLC
Members' Deficit
Number of member units exchange for license rights to develop, market and sell YN1203, InnoBation Bio CAR NK biomarker		78,555,554
Class B Member Units \| Liminatus Pharma, LLC
Members' Deficit
Percentage of allocation of annual revenue and expenses	51.00%
Percentage of voting interest	51.00%
Percentage of allocation of liquidation value	51.00%